Resources

Impact on Care Delivery Model

Dr. Steve Steinhubl shares how wearable biosensor technology and continuous monitoring impacts the care delivery model. 

What Automotive Manufacturing Figured Out In the 1950s That Can Transform Healthcare Delivery Today

New technologies in healthcare are allowing for innovative approaches to managing at-risk patient populations.  This piece explores how healthcare can borrow a page from just-in-time manufacturing to improve care of at-risk outpatient populations...

Heart Failure Management: Are You Ready for the Next 5 Years?

Heart failure is one of the most pressing issues in population health.  With almost 1 million hospitalizations per year, it represents a huge opportunity to improve outcomes and lower costs by leveraging technology.  Heart failure nurse practitioner Karen Larimer explores what's on tap to address the unmet needs for these patients.

Managing Health with Smartphone Technology

Dr. Steve Steinhubl of the Scripps Translational Science Institute shares his view on the potential smartphone technology and its data connectivity has on managing health.

How Scripps Translational Sciences Institute is Advancing Digital Medicine

Dr. Steve Steinhubl shares how Scripps Translational Science Institute is working with and advancing personalized and digital medicine.

Oncology Study with Janssen

PhysIQ partnered with Janssen to deploy accelerateIQ^TM to detect physiological anomalies during and after anti-cancer treatment. 

PhysIQ at the CNS Summit

PhysIQ presenting at the 2016 CNS Summit on the Innovation Showcase Panel to a community that is passionate about shaping the future with collaboration, innovation, and technology.

Continuous Physiological Data Impact on Heart Failure Management

As part of our ongoing Digital Medicine Discussions series, Dr Steve Steinhubl of the Scripps Translational Science Institute shares his thoughts on the impact continuous physiological data could have on heart failure management.

Fear of Data and Data of Fear

Our physiology can tell a story.  Some stories are fun.  Some are scary.

The Promise of Continuous Ambulatory Monitoring

Dr. Steve Steinhubl of the Scripps Translational Science Institute explores how continuous ambulatory physiology monitoring will transform how we think about and treat at-risk patients outside the hospital.

Broad Spectrum Monitoring vs. Biomarkers: Clinical Needs in an All-Cause Readmission Environment

As value-based healthcare drives evolving ambulatory clinical care models, health systems will be required to swap pateint centricity for disease centricity.  No where will this be more necessary than in post-acute care for comorbid populations.

Wearable Biosensors, Physiology Analytics, and Patient Self-Management

As part of our ongoing Digital Medicine Discussions series, Dr Steve Steinhubl of the Scripps Translational Science Institute shares his thoughts on how wearable biosensors and physiology analytics will transform how patients manage chronic disease.

A New (Real) World of Data

Integrating continuous physiology data and analytics into clinical trials in order to generate novel, highly-differentiated clinical endpoints for Rx product safety and efficacy validation.

Looking back to look forward: The continued evolution of hospitals and patient care delivery

Throughout the centuries, hospitals have evolved to address the needs of society and leverage technological advancement. Exploding healthcare costs have created another societal impetus for change. Dr. Robert Lynch explores how changing financial constructs and new technologies are helping hospitals make yet another shift in care delivery.

Dr. Robert Lynch served as Chief Executive Officer of Tulane University Hospital & Clinic from 2007 until 2014. Prior to that, Dr. Lynch was Director of the South Central Veterans Affairs Health Care Network, which covers all or parts of eight states and served a veteran population of 1.8 million with a budget over $2 billion.

Post-Acute Case Study

A topline discussion of physIQ’s collaboration with a 3-hospital integrated delivery network to validate the impact of continuous physiological visibility for post-acute heart failure patients enrolled in their 90-day bundle.

Taking "remote monitoring" to a new level: Deploying continuous physiology monitoring to manage suspected Ebola patients in Sierra Leone

PhysIQ, in collaboration with the Scripps Translational Science Institute, deployed a continuous remote monitoring solution to an Ebola treatment facility in Sierra Leone.  The program was sponsored by USAID, CDC, and the White House Office of Science and Technology Policy.  Within, you will learn more about the initiative and have access to the full publication within BMJ Global Health.